Cory Kasimov
Stock Analyst at Evercore ISI
(4.92)
# 216
Out of 4,683 analysts
1008
Total ratings
62.4%
Success rate
20.8%
Average return
Main Sectors:
Stocks Rated by Cory Kasimov
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NBIX Neurocrine Biosciences | Maintained: Buy | $210 → $215 | $153.37 | +40.18% | 17 | Aug 17, 2026 | |
| IMNM Immunome | Maintained: Buy | $40 | $29.39 | +36.12% | 8 | Aug 12, 2026 | |
| BMRN BioMarin Pharmaceutical | Maintained: Buy | $120 | $66.12 | +81.49% | 84 | Aug 7, 2026 | |
| CYTK Cytokinetics | Maintained: Buy | $80 → $100 | $77.46 | +29.10% | 11 | Aug 7, 2026 | |
| XENE Xenon Pharmaceuticals | Maintained: Buy | $80 | $60.42 | +32.41% | 7 | Aug 7, 2026 | |
| SRRK Scholar Rock Holding | Maintained: Buy | $65 | $58.25 | +11.59% | 2 | Aug 7, 2026 | |
| EWTX Edgewise Therapeutics | Maintained: Buy | $55 | $44.21 | +24.41% | 10 | Aug 7, 2026 | |
| VIR Vir Biotechnology | Maintained: Buy | $18 → $22 | $10.71 | +105.42% | 5 | Aug 6, 2026 | |
| RVMD Revolution Medicines | Maintained: Buy | $200 → $230 | $211.38 | +8.81% | 6 | Aug 6, 2026 | |
| ALNY Alnylam Pharmaceuticals | Maintained: Buy | $400 → $325 | $240.08 | +35.45% | 7 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $130 | $114.05 | +13.99% | 32 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $31.03 | +45.02% | 8 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $535 | $552.85 | -3.23% | 61 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $13.83 | +80.77% | 5 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $50 | $49.65 | +0.70% | 1 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $875 → $825 | $833.56 | -1.03% | 77 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $25 | $13.02 | +92.01% | 1 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $125 → $130 | $80.40 | +61.69% | 19 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $35 → $50 | $158.83 | -68.52% | 48 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $34 | $13.36 | +154.49% | 11 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $40 → $15 | $7.18 | +108.91% | 5 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 | $33.77 | +62.87% | 7 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $126 → $128 | $26.46 | n/a | 47 | Jul 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $91 → $84 | $17.62 | n/a | 26 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $30 → $33 | $49.21 | n/a | 48 | Jul 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $219 → $221 | $220.77 | n/a | 74 | Jul 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $19 | $30.57 | n/a | 48 | Jun 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 → $11 | $4.10 | n/a | 4 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $24 → $20 | $2.17 | n/a | 17 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $19 → $16 | $3.28 | n/a | 25 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $235 → $227 | $442.24 | n/a | 62 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $98 → $86 | $129.72 | n/a | 54 | Feb 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $61 | $21.30 | n/a | 8 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $17.39 | n/a | 3 | Jun 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $74 | $148.77 | n/a | 59 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $9.32 | n/a | 38 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $84.79 | n/a | 1 | Jul 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $42.17 | n/a | 1 | Nov 13, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $0.57 | n/a | 13 | Jun 26, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $4.16 | n/a | 14 | May 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $384 → $100 | $1,233.66 | n/a | 2 | Apr 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $277.06 | $9.31 | n/a | 1 | Dec 15, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $16 | $0.1489 | n/a | 6 | Dec 2, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.79 | n/a | 7 | Oct 30, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $1.92 | n/a | 1 | Sep 2, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $14 | $9.44 | n/a | 6 | Aug 11, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $65 → $68 | $63.57 | n/a | 5 | Jun 8, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $356.69 | n/a | 1 | Jan 13, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 → $18 | $9.83 | n/a | 2 | Dec 9, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $24 → $20 | $0.0001 | n/a | 2 | May 7, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $46.75 | n/a | 1 | Jun 4, 2013 |
Neurocrine Biosciences
Aug 17, 2026
Maintained: Buy
Price Target: $210 → $215
Current: $153.37
Upside: +40.18%
Immunome
Aug 12, 2026
Maintained: Buy
Price Target: $40
Current: $29.39
Upside: +36.12%
BioMarin Pharmaceutical
Aug 7, 2026
Maintained: Buy
Price Target: $120
Current: $66.12
Upside: +81.49%
Cytokinetics
Aug 7, 2026
Maintained: Buy
Price Target: $80 → $100
Current: $77.46
Upside: +29.10%
Xenon Pharmaceuticals
Aug 7, 2026
Maintained: Buy
Price Target: $80
Current: $60.42
Upside: +32.41%
Scholar Rock Holding
Aug 7, 2026
Maintained: Buy
Price Target: $65
Current: $58.25
Upside: +11.59%
Edgewise Therapeutics
Aug 7, 2026
Maintained: Buy
Price Target: $55
Current: $44.21
Upside: +24.41%
Vir Biotechnology
Aug 6, 2026
Maintained: Buy
Price Target: $18 → $22
Current: $10.71
Upside: +105.42%
Revolution Medicines
Aug 6, 2026
Maintained: Buy
Price Target: $200 → $230
Current: $211.38
Upside: +8.81%
Alnylam Pharmaceuticals
Aug 5, 2026
Maintained: Buy
Price Target: $400 → $325
Current: $240.08
Upside: +35.45%
Aug 5, 2026
Maintained: Buy
Price Target: $130
Current: $114.05
Upside: +13.99%
Aug 5, 2026
Maintained: Buy
Price Target: $45
Current: $31.03
Upside: +45.02%
Aug 4, 2026
Maintained: Buy
Price Target: $535
Current: $552.85
Upside: -3.23%
Aug 4, 2026
Maintained: Buy
Price Target: $25
Current: $13.83
Upside: +80.77%
May 26, 2026
Initiated Coverage: Buy
Price Target: $50
Current: $49.65
Upside: +0.70%
May 18, 2026
Maintained: Buy
Price Target: $875 → $825
Current: $833.56
Upside: -1.03%
May 12, 2026
Initiated Coverage: Buy
Price Target: $25
Current: $13.02
Upside: +92.01%
May 8, 2026
Maintained: Buy
Price Target: $125 → $130
Current: $80.40
Upside: +61.69%
May 4, 2026
Maintained: Hold
Price Target: $35 → $50
Current: $158.83
Upside: -68.52%
May 1, 2026
Maintained: Buy
Price Target: $34
Current: $13.36
Upside: +154.49%
Mar 27, 2026
Downgraded: Hold
Price Target: $40 → $15
Current: $7.18
Upside: +108.91%
Mar 17, 2026
Maintained: Buy
Price Target: $55
Current: $33.77
Upside: +62.87%
Jul 29, 2022
Maintained: Buy
Price Target: $126 → $128
Current: $26.46
Upside: n/a
Jul 28, 2022
Maintained: Hold
Price Target: $91 → $84
Current: $17.62
Upside: n/a
Jul 27, 2022
Maintained: Hold
Price Target: $30 → $33
Current: $49.21
Upside: n/a
Jul 20, 2022
Maintained: Hold
Price Target: $219 → $221
Current: $220.77
Upside: n/a
Jun 21, 2022
Downgraded: Hold
Price Target: $19
Current: $30.57
Upside: n/a
May 10, 2022
Maintained: Hold
Price Target: $14 → $11
Current: $4.10
Upside: n/a
May 5, 2022
Maintained: Hold
Price Target: $24 → $20
Current: $2.17
Upside: n/a
May 4, 2022
Maintained: Sell
Price Target: $19 → $16
Current: $3.28
Upside: n/a
Apr 28, 2022
Maintained: Hold
Price Target: $235 → $227
Current: $442.24
Upside: n/a
Feb 9, 2022
Maintained: Hold
Price Target: $98 → $86
Current: $129.72
Upside: n/a
Nov 19, 2021
Maintained: Buy
Price Target: $61
Current: $21.30
Upside: n/a
Jun 2, 2021
Rated: Buy
Price Target: n/a
Current: $17.39
Upside: n/a
Apr 29, 2021
Maintained: Hold
Price Target: $74
Current: $148.77
Upside: n/a
Feb 25, 2021
Maintained: Sell
Price Target: n/a
Current: $9.32
Upside: n/a
Jul 15, 2020
Downgraded: Sell
Price Target: n/a
Current: $84.79
Upside: n/a
Nov 13, 2019
Maintained: Buy
Price Target: n/a
Current: $42.17
Upside: n/a
Jun 26, 2018
Maintained: Sell
Price Target: n/a
Current: $0.57
Upside: n/a
May 11, 2017
Reiterated: Sell
Price Target: n/a
Current: $4.16
Upside: n/a
Apr 11, 2017
Maintained: Buy
Price Target: $384 → $100
Current: $1,233.66
Upside: n/a
Dec 15, 2015
Reiterated: Buy
Price Target: $277.06
Current: $9.31
Upside: n/a
Dec 2, 2015
Rated: Buy
Price Target: $16
Current: $0.1489
Upside: n/a
Oct 30, 2015
Reiterated: Hold
Price Target: n/a
Current: $1.79
Upside: n/a
Sep 2, 2015
Initiated Coverage: Buy
Price Target: $20
Current: $1.92
Upside: n/a
Aug 11, 2015
Reiterated: Buy
Price Target: $10 → $14
Current: $9.44
Upside: n/a
Jun 8, 2015
Maintained: Hold
Price Target: $65 → $68
Current: $63.57
Upside: n/a
Jan 13, 2015
Maintained: Hold
Price Target: n/a
Current: $356.69
Upside: n/a
Dec 9, 2014
Rated: Buy
Price Target: $20 → $18
Current: $9.83
Upside: n/a
May 7, 2014
Rated: Buy
Price Target: $24 → $20
Current: $0.0001
Upside: n/a
Jun 4, 2013
Downgraded: Hold
Price Target: n/a
Current: $46.75
Upside: n/a